ANN ARBOR - ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, Tuesday announced new appointments and promotions involving the company’s board of directors and management team. The company has appointed Christine (Chris) Gibbons as a new, independent member of its board of directors, replacing departing
NEW YORK - Cancer is caused by mistakes in DNA, and a new study finds that in most cancer cases, these mistakes are completely random; they're not due to heredity or environmental factors, but rather the result of random errors. The mistakes, or mutations, cause cancer to happen because even a tiny error in DNA
ANN ARBOR - Thin parts of the cell membranes of neurons turn out to be particularly vulnerable to a protein that collects in the brain of people with Alzheimer's disease, according to a University of Michigan researcher. The discovery could open an avenue for developing treatments for Alzheimer's disease that work within the cell's membrane.
ANN ARBOR - A new interdisciplinary health sciences resource center at the University of Michigan has received an $11.7 million award from the National Institutes of Health to advance regenerative medicine. The center, led by the School of Dentistry, brings together scientists, engineers and clinicians from several U-M departments in collaboration with researchers at the
ANN ARBOR - Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company, announced that it has closed on the sale of 1.3 million shares of stock to a select group of accredited investors that will raise about $12.5 million, providing cash flow through 2018. Gemphire Therapeutics will use the money to fund development costs, the company said
ANN ARBOR - A University of Michigan startup that's developing a non-invasive way to remove diseased tissue from cancer patients using high-intensity ultrasound has attracted $8.3 million in Series B financing. The investment will help advance clinical trials of HistoSonics' Robotic Assisted Sonic Therapy—an innovative tissue-destruction technology targeted for liver cancer and other solid tumor
ANN ARBOR - States that participated in Medicaid expansion under the Affordable Care Act saw increased insurance rates and access to care, less worry about paying medical bills, but also longer wait times among low-income residents, according to new research. In a study published in the New England Journal of Medicine, Sarah Miller of the
ROYAL OAK - What does it take for a medical device to get approved by the Federal Drug Administration for commercialization? Brent Nowak, PhD, executive director of the Applied Medical Device Institute of Grand Valley State University, explains how the process works. Nowak is interviewed on this segment of M2 TechCast by Keith Brophy, state
ANN ARBOR - On Thursday, MichBio will host a networking breakfast and moderated discussion at the Kensington Hotel on State Street in Ann Arbor with acclaimed networking guru Kelly Hoey, whose recent book BUILD YOUR DREAM NETWORK helps readers build and activate powerful networks to achieve both their long and short-term goals. Hoey is a
ANN ARBOR - Genomenon has launched Mastermind, an analytic and data visualization tool that accelerates gene and variant curation by providing immediate insight into millions of scientific articles from primary medical literature. Mastermind delivers a comprehensive knowledge base of disease-gene-variant relationships curated from primary medical literature, organized into clinical categories, and prioritized by the strength
